Effects of ace inhibition and beta-blockade on collagen remodelling in the heart of bio 14.6 hamsters

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 1, 1996, Pages 43-49

  Mansoor, Abdul M ^a   Honda, Masaaki ^a   Kuramochi, Takehiko ^a   Tanaka, Koichi ^a   Morioka, Shigefumi ^a   Takabatake, Toshikazu ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Atenolol; Bio 14.6 Syrian hamsters; Cardiac hypertrophy; Collagen concentration; Collagen type; Enalapril; Fib hamsters

Indexed keywords

ADRENALIN; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ANIMAL; ARTICLE; BLOOD; DOSE RESPONSE; DRUG EFFECT; HAMSTER; HEART; MALE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ATENOLOL; CATECHOLAMINES; COLLAGEN; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENALAPRIL; EPINEPHRINE; HEART; MALE;

EID: 0029690844     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb03060.x     Document Type: Article

References (46)

1. Borg TK, Ranson WF, Moslehy FA, Cauffield JB. Structural basis of ventricular stiffness. Lab. Invest. 1981; 44: 49-54.
2. Weber KT. Cardiac interstitium in health and disease: The fibrillar collagen network. J. Am. Coll. Cardiol. 1989; 13: 1637-42.
3. Mirsky I, Laks MM. Time course of changes in the mechanical properties of the canine right and left ventricles during hypertrophy caused by pressure overload. Circ. Res. 1980; 46: 530-42.
4. Mortz W, Struer BE. Left ventricular function and collagen content after regression of hypertensive hypertrophy. Hypertension 1989; 13: 43-50.
5. Weber KT, Janicki JS, Pick R et al. Collagen in the hypertrophied, pressure overload myocardium. Circulation 1987; 75: 40-7.
6. Weber KT, Janicki JS, Shroff SG, Pick R, Chen RM, Bashey RI. Collagen remodeling of the pressure-overload hypertrophied non-human primate myocardium. Circ. Res. 1988; 62: 757-65.
7. Iimoto DS, Covell JW, Harper E. Increase in cross-linking of type I and type III collagens associated with volume-overload hypertrophy. Circ. Res. 1988; 63: 399-408.
8. Goto Y, Honda M, Yoshikane H, Morioka S, Ooshima A, Moriyama K. Remodeling of collagens in human hypertensive hearts: Collagen contents, proportion and distribution of type I, III, and V collagen. Jpn. Circ. J. 1990; 54: 717 (Abstract).
9. Honda M, Yamada S, Goto Y et al. Biochemical and structural remodeling of collagen in the right ventricular hypertrophy induced by monocrotaline. Jpn. Circ. J. 1992; 56: 392-403.
10. Kuzuo H, Honda M, Ishinaga Y et al. Angiotensin converting enzyme inhibitor, captopril, inhibits cardiac hypertrophy without changing collagen types and concentration in spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 1993; 20: 253-60.
11. Mercadier JJ, Lompre AM, Wisnewsky C et al. Myosin isoenzymic changes in several models of rat cardiac hypertrophy. Circ. Res. 1981; 49: 525-32.
12. Alpert NR, Hamrell BB, Halpern W. Mechanical and biochemical correlates of cardiac hypertrophy. Circ. Res. 1974; 35: 71-81.
13. Bing OHL, Fanburg BL, Brooks WW, Matsushita S. The effect of lathyrogen-amino-proprinitril (BAPN) on the mechanical properties of experimentally hypertrophied rat cardiac muscle. Circ. Res. 1978; 43: 632-7.
14. Mukherjee, D, Sen S. Collagen phenotypes during development and regression of myocardial hypertrophy in spontaneously hypertensive rats. Circ. Res. 1990; 67: 1474-80.
15. Honda M, Goto Y, Kuzuo H et al. Biochemical remodeling of collagen in the heart of spontaneously hypertensive rats: Prominent increase in type V collagen. Jpn. Circ. J. 1993; 57: 434-41.
16. Tanaka K, Honda M, Kuramochi T et al. Different effects of an ACE inhibitor and a calcium antagonist on protein metabolism in rats with right ventricular hypertrophy. J. Hypertension 1994; 12: 1147-54.
17. Gertz EW. Syrian hamster: A possible model of human disease. Prog. Exp. Tumor Res. 1972; 16: 242-60.
18. Ishikawa S, Honda M, Yamada S, Morioka S, Moriyama K. Biventricular down-regulation of beta-adrenergic receptors in right ventricular hypertrophy induced by monocrotaline. Jpn. Circ. J. 1991; 55: 1077-85.
19. Naruse M, Naruse K, Kurimoto F et al. Evidence for the existence of des-asp1-angiotensin II in human uterine and adrenal tissues. J. Clin. Endocrinol. Metab. 1985; 61: 480-3.
20. Sole MJ, Lo CM, Kamble AB, Sonnenblick HE, Wartman RJ. Tyrosine hydroxylase activity in the heart of the cardiomyopathic Syrian hamster. J. Mol. Cell. Cardiol. 1977; 9: 225-33.
21. Strobeck JE, Factor SM, Bhan A et al. Hereditary and acquired cardiomyopathies in experimental animals: Mechanical, biochemical, and structural features. Ann. N.Y. Acad. Sci. 1979; 317: 59-88.
22. Rona G, Chappel CI, Balazs T, Gaudry R. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Arch. Pathol. 1959; 67: 443-55.
23. Raab W. The nonvascular metabolic myocardial vulnerability factor in coronary heart disease. Am. Heart J. 1963; 66: 685-706.
24. Francis GP, Goldsmith SR, Levine TB, Olivari MT, Cohn JN. The neurohumoral axis in congestive heart failure. Ann. Int. Med. 1984; 101: 370-7.
25. Källfelt BJ, Waldenstrom AP, Hjalmarson AC. Effects of adrenalin in vivo on protein synthesis, mechanical performance and sensitivity to ischemia in the perfused rat heart. J. Mol. Cell. Cardiol. 1977; 9: 383-98.
26. Mattioli AV, Mattioli G. Neurohumoral changes in patients with heart failure treated chronically with beta-blockers. Cardiologia (Italy) 1991; 36: 549-56.
27. Mukherjee JB, Kulkarni PV, Haghani Z, Sutko JL. Identification and characterization of angiotensin II receptors in myocardial sarcolemma. Biochem. Biophys. Res. Commun. 1982; 105: 575-81.
28. 125I]-angiotensin to a membrane component of 116000 daltons. J. Biol. Chem. 1984; 259: 8106-14.
29. Rogers TB, Gaa ST, Allen IS. Identification and characterization of functional angiotensin receptors on cultured myocytes. J. Pharmacol. Exp. Ther. 1986; 236: 438-44.
30. Dzau VJ, Ingelfinger JR, Pratt RE. Regulation of tissue renin and angiotensin gene expressions. J. Cardiovasc. Pharmacol. 1986; 8 (Suppl. 10): S11-16.
31. Baker KM, Chemin MI, Wixson SK, Aceto JF. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am. J. Physiol. 1990; 259, H324-31.
32. Geisterfer AAT, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 1988; 62: 749-56.
33. Berk BC, Vekshteuin V, Gordon HM, Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 1989; 13: 305-14.
34. Kato H, Suzuki H, Tajima S et al. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J. Hypertension 1991; 9: 17-22.
35. Tan LB, Jalil JE, Pick R, Janicki JS, Weber KT. Cardiomyocyte necrosis induced by angiotensin II. Circ. Res. 1991; 69: 1185-95.
36. Isaacson JS, Reid IA. Importance of indigenous angiotensin II in the cardiovascular responses to sympathetic stimulation in conscious rabbits. Circ. Res. 1990; 66: 662-71.
37. Forfar JC. Neuroendocrine activation in congestive heart failure. Am. J. Cardiol. 1991; 67: 3C-5C.
38. Wolf G, Killen PD, Neilson EG. Intracellular signaling of transcription and secretion of type IV collagen after angiotensin II-induced cellular hypertrophy in cultured proximal tubular cells. J. Cell Reg. 1991; 2: 219-27.
39. Wolf G, Haberstroh U, Neilson EG. Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am. J. Pathol. 1992; 140: 95-107.
40. Urata H, Ganten D. Cardiac angiotensin II formation: The angiotensin-I converting enzyme and human chymase. Eur. Heart J. 1993; 14 (Suppl. I): 177-82.
41. Mangiapane ML, Rauch AL, MacAndrew JT et al. Vasoconstrictor action of angiotensin I-convertase and the synthetic substrate (pro11,D-Ala12)-angiotensin I. Hypertension 1994; 23: 857-60.
42. Okunishi H, Miyazaki M, Toda N. Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall. J. Hypertension 1984; 2: 277-84.
43. Okunishi H, Miyazaki M, Okamura T, Tada N. Different distribution of two types of angiotensin II-generating enzymes in the aortic wall. Biochem. Biophys. Res. Commun. 1987; 149: 1186-92.
44. Okunishi H, Oka Y, Shiota N, Kawamoto T, Song K, Miyazaki M. Marked species-difference in the vascular angiotensin II-forming pathways: Humans versus rodents. Jpn. J. Pharmacol. 1993; 62: 207-10.
45. Baker KM, Aceto JF. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am. J. Physiol. 1990; 259: H610-18.
46. Lowry OH, Ravensbroush NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J. Biol. Chem. 1951; 193: 265-75.